During the last session, Viking Therapeutics Inc (NASDAQ:VKTX)’s traded shares were 3.51 million, with the beta value of the company hitting 1.17. At the end of the trading day, the stock’s price was $68.86, reflecting an intraday gain of 5.82% or $3.79. The 52-week high for the VKTX share is $99.41, that puts it down -44.37 from that peak though still a striking 87.98% gain since the share price plummeted to a 52-week low of $8.28. The company’s market capitalization is $7.53B, and the average trade volume was 6.40 million shares over the past three months.
Viking Therapeutics Inc (NASDAQ:VKTX) trade information
Viking Therapeutics Inc (VKTX) registered a 5.82% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 5.82% in intraday trading to $68.86, hitting a weekly high. The stock’s 5-day price performance is 6.48%, and it has moved by -14.81% in 30 days. Based on these gigs, the overall price performance for the year is 246.38%.
Viking Therapeutics Inc (VKTX) estimates and forecasts
Statistics show that Viking Therapeutics Inc has underperformed its competitors in share price, compared to the industry in which it operates. Viking Therapeutics Inc (VKTX) shares have gone up 546.57% during the last six months, with a year-to-date growth rate less than the industry average at -20.88% against 12.90.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -18.89%. While earnings are projected to return -20.48% in 2024, the next five years will return 40.00% per annum.
VKTX Dividends
Viking Therapeutics Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
